We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA批准了神经保护剂Privosegtor治疗视神经炎的注册试验设计。了解该药物如何改变神经眼科，以及SPA协议带来的前景。
